RNA helicase A (RHA) is conserved in many organisms and has numerous cellular functions. Human RHA is required for RNA export from the nucleus (Tang et al. (1999) MCB 19, 3540) and the Drosophila homolog, MLE, is required for dosage compensation in male flies (Kuroda et al. (1991) Cell 66, 935). We are characterizing the C. elegans strain
tm329 that contains a deletion in
rha-1, the C. elegans homolog of RHA. These worms develop normally at 16-17 degrees C, but at 25.5 degrees C, hermaphrodites and males have small gonads containing few germ cells, most with abnormal nuclear morphology. Staining of the mutant gonads with an antibody against a mitosis marker (phosphorylated serine 10 on histone H3) demonstrates that there are fewer cells undergoing mitosis in the mutant worms compared to N2 worms. The germ cells are not degraded by apoptosis (tested using uptake of acridine orange). Meiotic cells were labeled in the mutants with an antibody against HIM-3. Meoisis starts in the middle of the mutant gonads but does not proceed properly, and few gametes are formed. At least 80% of both male and hermaphrodite
rha-1(
tm329) worms grown at 25.5 degrees C are sterile, with the fertile worms producing approximately 10 offspring, compared to 140 for N2 worms grown under the same conditions. To test whether
rha-1 is involved in a known germline pathway,
rha-1(
tm329) embryos and young adult germlines were stained with antibodies directed against the P-granule proteins GLH-1 and PGL-1. Both proteins were properly distributed throughout the development of the
rha-1(
tm329) mutants, and the numbers of P-granules in embryos and around the germ cell nuclei in both mutant and wild-type worms were similar. The
rha-1(
tm329) mutant worms have some phenotypic similarities to Mes mutants, namely a maternal effect phenotype, underproliferated gonads, and similar abnormal germ cell nuclear morphologies. Additional experiments testing for other similarities between Mes mutants and
rha-1(
tm329) mutants will be discussed. We are grateful to the C. elegans Gene Knockout Consortium for the
tm329 strain and to K. Bennett, S. Strome, and M. Zetka for antibodies.